{"name": "Action Pharma",
 "permalink": "action-pharma",
 "crunchbase_url": "http://www.crunchbase.com/company/action-pharma",
 "homepage_url": "http://www.actionpharma.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2000,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "ils@actionpharma.com",
 "phone_number": "+(45) 2020 3687 ",
 "description": "",
 "created_at": "Sat Jul 17 01:59:43 UTC 2010",
 "updated_at": "Sat Jul 17 01:59:42 UTC 2010",
 "overview": "\u003Cp\u003EAction Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company\u00e2\u20ac\u2122s product pipeline includes AP214, a modified \u00c3\u0090MSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.\u003C/p\u003E",
 "image": null,
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Ingelise",
      "last_name": "Saunders",
      "permalink": "ingelise-saunders",
      "image": null}},
   {"is_past": false,
    "title": "COO",
    "person":
     {"first_name": "Soren",
      "last_name": "Nielsen",
      "permalink": "soren-nielsen",
      "image": null}},
   {"is_past": false,
    "title": "CSO",
    "person":
     {"first_name": "Thomas",
      "last_name": "Jonassen",
      "permalink": "thomas-jonassen",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$6.3M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://onbiovc.com/action-pharma-as-series-c-63m/",
    "source_description": "Action Pharma, A/S: Series C $6.3M",
    "raised_amount": 6300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 7,
    "funded_day": 16,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Sunstone Capital",
         "permalink": "sunstone-capital",
         "image":
          {"available_sizes":
            [[[150,
               45],
              "assets/images/resized/0003/0832/30832v2-max-150x150.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-250x250.png"],
             [[216,
               66],
              "assets/images/resized/0003/0832/30832v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Global Life Science Ventures",
         "permalink": "global-life-science-ventures",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/9922/59922v1-max-150x150.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-250x250.jpg"],
             [[208,
               80],
              "assets/images/resized/0005/9922/59922v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SLS Venture",
         "permalink": "sls-venture",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0007/1578/71578v1-max-150x150.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-250x250.png"],
             [[250,
               47],
              "assets/images/resized/0007/1578/71578v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "InnovationsKapital",
         "permalink": "innovationskapital-3",
         "image":
          {"available_sizes":
            [[[138,
               67],
              "assets/images/resized/0008/0367/80367v1-max-150x150.jpg"],
             [[138,
               67],
              "assets/images/resized/0008/0367/80367v1-max-250x250.jpg"],
             [[138,
               67],
              "assets/images/resized/0008/0367/80367v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Brendstrupgaardsvej 102 ",
    "address2": "",
    "zip_code": "DK-8200",
    "city": "\u00c3\u2026rhus ",
    "state_code": null,
    "country_code": "DNK",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}